Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bael leaf refers to the leaves of the *Aegle marmelos* tree (commonly known as bael), a plant native to Southeast Asia and widely used in traditional medicine systems such as Ayurveda. Bael leaves are rich in bioactive compounds including tannins, aegeline, skimmianine, cineol, and eugenol. Traditionally used for their anti-inflammatory, antibacterial, antifungal, antioxidant and mild laxative properties[2][4][5][6], bael leaves are employed to support digestive health (treating constipation and dyspepsia), manage diarrhea and dysentery (as an astringent), soothe inflamed skin or rashes[2], promote wound healing[6], relieve coughs (as an expectorant)[5], and potentially lower blood sugar levels[1][3]. Extracts from the leaves have also shown radioprotective effects in laboratory studies by scavenging free radicals[4]. The main mechanism of action is attributed to tannins that reduce inflammation in the gut mucosa; other phytochemicals may contribute antimicrobial or immunomodulatory effects. Bael leaves are not approved pharmaceuticals but are widely used as dietary supplements or herbal remedies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bael leaf.